Therapeutic potential of JAK inhibitors in juvenile idiopathic arthritis-associated uveitis

Expert Rev Clin Immunol. 2023 Jul-Dec;19(7):689-692. doi: 10.1080/1744666X.2023.2207823. Epub 2023 May 11.

Ilaria Maccora^{1

2

3}, Preston Land^{3

4}, Virginia Miraldi Utz^{4

5}, Sheila T Angeles-Han^{3

4

5}

¹ NeuroFARBA Department, University of Florence, Florence, Italy.
² Rheumatology Unit, ERN ReCONNET center, Meyer Children's Hospital IRCCS, Florence, Italy.
³ Division of Rheumatology, Cincinnati Children's Hospital Medical Center and Department of Pediatrics, University of Cincinnati, Cincinnati, OH.
⁴ Abrahamson Pediatric Eye Institute, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, OH, USA.
⁵ Department of Ophthalmology, University of Cincinnati, Cincinnati, OH, USA.

No abstract available

Keywords: Baricitinib; JAK-inhibitor; JIA; Uveitis; pediatric uveitis; tofacitinib; treatment; upadacitinib.

Publication types